Skip to main content
SpringerLink
Log in

Subdermale kontrazeptive Implantate

Subdermal contraceptive implants

  • Leitthema
  • Published:
Gynäkologische Endokrinologie Aims and scope

Zusammenfassung

Der vorliegende Beitrag erläutert die Vor- und Nachteile des einzigen in Europa verfügbaren subdermalen kontrazeptiven Implantats – Implanon®. Die kontrazeptive Effizienz ist bei korrekter Anwendung hoch. Das Nebenwirkungsprofil ist insgesamt als günstig einzustufen. Eine entsprechende Beratung bei eventuell auftretenden Blutungsstörungen inklusive möglicher Therapieoptionen sowie die möglichst oberflächliche Insertion sind allerdings zu beachten.

Abstract

This report describes the advantages and disadvantages of Implanon®, the only subdermal contraceptive device available in Europe. Contraceptive efficacy is high with correct insertion. Overall, the side effect profile is acceptable. Clinical aspects concerning counseling and insertion as well as possible bleeding disturbances and potential therapeutic options are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Affandi B, Korver T, Geurts TB, Coelingh Bennink HJ (1999) A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for ≤ 4 years. Contraception 59:167–174

    Article  PubMed  CAS  Google Scholar 

  2. Ahrendt HJ, Egarter C (2011) Blutungsstörungen unter reiner Gestagen-Langzeitkontrazeption mit subdermalen Implantaten. Frauenarzt 52:2–7

    Google Scholar 

  3. Ahrendt HJ, Egarter C (2011) Management von Zusatzblutungen unter subdermalen Implantaten. Frauenarzt 52:493–501

    Google Scholar 

  4. Beerthuizen R, Beek A van, Massai R et al (2000) Bone mineral density during long-term use of the progestogen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 15:118–122

    Article  PubMed  CAS  Google Scholar 

  5. Biswas A, Viegas OA, Roy AC (2003) Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids – a randomized comparative study. Contraception 68:189–193

    Article  PubMed  CAS  Google Scholar 

  6. Biswas A, Biswas S, Viegas OA (2004) Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests – a randomized comparative study with Norplant implants. Contraception 70:379–382

    Article  PubMed  CAS  Google Scholar 

  7. Bitzer J, Tschudin S, Alder J (2004) Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care 9:278–284

    Article  PubMed  CAS  Google Scholar 

  8. Blumenthal PD, Voedisch A, Gemzell-Danielsson K (2011) Strategies to prevent unintended pregnancy: increasing use of longacting reversible contraception. Hum Reprod Update 17:121–137

    Article  PubMed  CAS  Google Scholar 

  9. Croxatto HB, Makarainen L (1998) The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception 58:91S–97S

    Article  PubMed  CAS  Google Scholar 

  10. Croxatto HB, Urbancsek J, Massai R et al (1999) A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod 14:976–981

    Article  PubMed  CAS  Google Scholar 

  11. Croxatto HB (2000) Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 5:21–28

    PubMed  CAS  Google Scholar 

  12. Davies GC, Feng LX, Newton JR et al (1993) Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception 47:251–261

    Article  PubMed  CAS  Google Scholar 

  13. Edwards JE, Moore A (1999) Implanon. A review of clinical studies. Br J Fam Plann 24:3–16

    PubMed  CAS  Google Scholar 

  14. Egberg N, Beek A van, Gunnervik C et al (1998) Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial. Contraception 58:93–98

    Article  PubMed  CAS  Google Scholar 

  15. Flores JB, Balderas ML, Bonilla MC et al (2005) Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. Int J Gynaecol Obstet 90:228–233

    Article  PubMed  CAS  Google Scholar 

  16. Funk S, Miller MM, Mishell DR Jr et al (2005) Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 71:319–326

    Article  PubMed  CAS  Google Scholar 

  17. Harrison-Woolrych M, Hill R (2005) Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 71:306–308

    Article  PubMed  Google Scholar 

  18. Hidalgo MM, Lisondo C, Juliato CT et al (2006) Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants. Contraception 73:532–536

    Article  PubMed  CAS  Google Scholar 

  19. Hohmann H, Creinin MD (2007) The contraceptive implant. Clin Obstet Gynecol 50:907–917

    Article  PubMed  Google Scholar 

  20. Implanon Package Insert (2006) Organon USA Inc. Roseland

  21. Lakha F, Glasier AF (2006) Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception 74:287–289

    Article  PubMed  Google Scholar 

  22. Lidegaard Ø, Nielsen LH, Skovlund CW, Løkkegaard E (2012) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001–10. BMJ 344:e2990

    Article  PubMed  Google Scholar 

  23. Makarainen L, Beek A van, Tuomivaara L et al (1998) Ovarian function during the use of a single contraceptive implant: implanon compared with Norplant. Fertil Steril 69:714–721

    Article  PubMed  CAS  Google Scholar 

  24. Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS (2008) The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 13:13–28

    Article  PubMed  CAS  Google Scholar 

  25. Mansour D, Fraser IS, Walling M et al (2008) Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 34:9–12

    Article  PubMed  Google Scholar 

  26. Mansour D (2009) UK provision for removal of non-palpable contraceptive implants. J Fam Plann Reprod Health Care 35:3–4

    Article  PubMed  Google Scholar 

  27. Mansour D, Mommers E, Teede H et al (2010) Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 82:243–249

    Article  PubMed  Google Scholar 

  28. Meckstroth KR, Darney PD (2001) Implant contraception. Semin Reprod Med 19:339–354

    Article  PubMed  CAS  Google Scholar 

  29. Meirik O, Farley TM, Sivin I (2001) Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization. Obstet Gynecol 97:539–547

    Article  PubMed  CAS  Google Scholar 

  30. Palomba S, Falbo A, Di Cello A et al (2012) Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecol Endocrinol 28:710–721

    Article  PubMed  CAS  Google Scholar 

  31. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S et al (2000) Effects of the etonogestrelreleasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device). Contraception 62:239–246

    Article  PubMed  CAS  Google Scholar 

  32. Shulman LP, Gabriel H (2006) Management and localization strategies for the nonpalpable Implanon rod. Contraception 73:325–330

    Article  PubMed  Google Scholar 

  33. Taneepanichskul S, Reinprayoon D, Thaithumyanon P et al (2006) Effects of the etonogestrelreleasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 73:368–371

    Article  PubMed  CAS  Google Scholar 

  34. Weisberg E, Hickey M, Palmer D et al (2006) A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 21:295–302

    Article  PubMed  CAS  Google Scholar 

  35. Weisberg E, Hickey M, Palmer D et al (2009) A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Hum Reprod 24:1852–1861

    Article  PubMed  CAS  Google Scholar 

  36. Wenzl R, Beek A van, Schnabel P et al (1998) Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception 58:283–288

    Article  PubMed  CAS  Google Scholar 

Download references

Einhaltung der ethischen Richtlinien

Interessenkonflikt. C. Egarter erhielt von MSD und Bayer/Schering Honorare für Studien, Vorträge sowie Expertentreffen auf dem Gebiet der Kontrazeption. Dieser Beitrag beinhaltet keine Studien an Menschen und Tieren.

Author information

Authors and Affiliations

  1. Klin. Abt. f. Gyn. Endokrinologie und Reproduktionsmedizin, Universitätsfrauenklinik Wien, Medizinische Universität Wien, Währinger Gürtel 18–20, 1090, Wien, Österreich

    C. Egarter

Authors
  1. C. Egarter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Egarter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Egarter, C. Subdermale kontrazeptive Implantate. Gynäkologische Endokrinologie 11, 175–183 (2013). https://doi.org/10.1007/s10304-012-0536-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-012-0536-0

Schlüsselwörter

Keywords

Search

Navigation